SR One
34 portfolio companies · 7 on the map · $1.8B raised · 6 cities
Portfolio map
7 SR One portfolio companies on the map.
Portfolio companies

CRISPR Therapeutics
Boston
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Biotechnology Research$957MEst. 2013
Mineralys Therapeutics
Radnor
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Biotechnology Research$740.5MEst. 2020Hiring fast
ARS Pharmaceuticals Operations
San Diego
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
Pharmaceutical Manufacturing$75MEst. 2015
Nomic Bio
Montreal
Nomic develops a high-throughput proteomics platform to profile proteins at large scale, making biology easier to measure. Spun from McGill University, it is headquartered in Montreal with a Boston facility, partners with pharma including G
Biotechnology$42M
ADARx Pharmaceuticals
San Diego
ADARx Pharmaceuticals, Inc., a San Diego-based clinical-stage biotechnology company, develops RNA-targeting platforms and oligonucleotide delivery technologies to inhibit, degrade, or edit disease-causing mRNA, pursuing programs across gene
BiotechnologyEst. 2019
Principia Biopharma
South San Francisco
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
BiotechnologyPublicEst. 2008Hiring fastCORXEL Pharmaceuticals
Berkeley Heights
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
Biotechnology ResearchSeries DEst. 2019
More portfolio companies
27 more SR One investments we track beyond the map.
Nimbus TherapeuticsBoston · Private Equity
Avenzo TherapeuticsSan Diego · Series B
CHARM TherapeuticsLondon · Series B
Fore BiotherapeuticsPhiladelphia · Series D
Dren BioFoster City · Series B
ProgynyNew York · Series B
ORIC PharmaceuticalsSouth San Francisco · Post-IPO Equity
Simcha TherapeuticsNew Haven · Series B
KALA BIOWaltham · Post-IPO Equity
PulmocideLondon · Series C
Propeller HealthMadison · Series D
Ancora BiotechPalo Alto · Series A
ZappRxBoston · Series B
AGTCAlachua · Series B
Morphic TherapeuticWaltham · Series B
Bird Rock BioLa Jolla · Series B
Pandion TherapeuticsCambridge · Series B
F-Star TherapeuticsCambridge · Post-IPO Equity
HTG Molecular DiagnosticsTucson · Series D
Translate BioLexington · Series C
Turning Point TherapeuticsSan Diego · Private Equity
IlluminOss MedicalEast Providence · Series C
MicroMass CommunicationsCary · Venture
iPierianSouth San Francisco · Venture
POINT BiomedicalSan Carlos · Private Equity
Protein ForestLexington · Series A
Xenogen CorporationAlameda · Series E
Portfolio map
7 SR One portfolio companies on the map.